Bacteroides fragilis arthritis in a patient with sickle cell disease.
Nehra
A
A
Mehta
R N
RN
Encarnacion
C
C
D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*; D001442:Bacteroides Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D001441:Bacteroides fragilis; D015313:Cefotetan / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D019818:Clavulanic Acid; D015313:Cefotetan; D013982:Ticarcillin